2016 American Transplant Congress Archives - Page 94 of 180

Kidney Transplantation Offers a Significant Survival Advantage Compared to Waitlisting, a Single Centre Experience.

G. Spanos,¹ N. Duncan,¹ P. Brookes,¹ S. Singh,¹ D. Goodall,¹ D. Moutzouris,¹ E. Evangelou,² M. Loucaidou.¹
Kidney Transplantation with Strong Preformed Donor-Specific Antibodies: Impact of C1q-Binding Ability.

J. Malheiro,¹ S. Tafulo,² S. Santos,¹ M. Costa,¹ L. Martins,¹ L. Dias,¹ A. Henriques.¹
Kidney Transplantation: Do Early Urinary Tract Complications Influence Long-Term Graft Survival?

E. Arpali, D. Kaufman, H. Sollinger.
Kidney Transplants from Anuric Deceased Donors on Renal Replacement Therapy.

W. Bry, J. Bellingham, S. Katznelson, P. Patel, K. Ueda, H. Mahanty, N. Neidlinger, A. Hassoun, V. Peddi.
Kidney Waitlist Management with Lean Six Sigma.

V. Arelin,¹ J. Schaefer,³ H. Haller,¹ I. Ackermann,² H. Schrem.²
Kinetics of Cytomegalovirus Load in Kidney Transplant Recipients Receiving Everolimus or Mycophenolate Sodium and No Pharmacological Prophylaxis.

G. Basso, C. Felipe, A. Ferreira, M. Cristelli, N. Oliveira, T. Sandes-Freitas, J. Mansur, L. Viana, W. Aguiar, E. Campos, M. Gerbasi-DeLima, H. Tedesco-Silva, J. Medina-Pestana.
LACE Index Risk Assessment Tool Predicts Liver Transplant Readmissions.

A. Masoumi,¹ R. Barth,² J. LaMattina,² D. Bruno,² L. Hebert,¹ N. Schluterman,³ S. Hanish.²
Landscape of Hypertension Treatment in Former Kidney Donors.

L. Ferrara, O. Sanchez, D. Berglund, A. Matas, H. Ibrahim.
Laparoscopically Assisted Living Donor Hepatectomy Is Safe and Cost Effective.

M. Akoad, M. Simpson, E. Pomfret.
Large Single-Center Experience of Sofosbuvir and Ledipasvir Therapy for the Treatment of Post-Liver Transplant Patients with Hepatitis C Virus.

J. Wedd, R. Ford, J. Norvell, S. Parekh, N. Cheng, N. Young, A. Patel, R. Maheshwari, R. Vora, O. Mgbemena, J. Spivey, A. Pillai.